← back to search

Deanna L. Kelly

University of Maryland, Baltimore · US
Area of research
Psychiatry and Mental health · Biological Psychiatry
Research interest
Research interests include Schizophrenia research and treatment, Tryptophan and brain disorders, Bipolar Disorder and Treatment, and Celiac Disease Research and Management.
h-index
51
citations
10,097
works
320
NIH funding
primary concept
email

Recent publications

Letter to the FDA Proposing Major Changes in the US Clozapine Package Insert Supported by Clozapine Experts Worldwide. Part I
Journal of Clinical Psychopharmacology 2025cited by 21position: middledoi
Letter to the FDA Proposing Major Changes in the US Clozapine Package Insert Supported by Clozapine Experts Worldwide. Part II
Journal of Clinical Psychopharmacology 2025cited by 21position: middledoi
Absolute neutrophil count and adverse drug reaction monitoring during clozapine treatment: consensus guidelines from a global Delphi panel
The Lancet Psychiatry 2025cited by 16position: middledoi
FDA Eliminates the Clozapine REMS—What Comes Next?
JAMA Psychiatry 2025cited by 12position: firstdoi
Correction: An International Adult Guideline for Making Clozapine Titration Safer by Using Six Ancestry-Based Personalized Dosing Titrations, CRP, and Clozapine Levels
Pharmacopsychiatry 2022cited by 5position: middledoi
An International Adult Guideline for Making Clozapine Titration Safer by Using Six Ancestry-Based Personalized Dosing Titrations, CRP, and Clozapine Levels
Pharmacopsychiatry 2021cited by 250position: middledoi
Consensus statement on the use of clozapine during the COVID-19 pandemic
Journal of Psychiatry and Neuroscience 2020cited by 157position: middledoi
Blood Levels to Optimize Antipsychotic Treatment in Clinical Practice
The Journal of Clinical Psychiatry 2020cited by 141position: middledoi
Blood–brain barrier and intestinal epithelial barrier alterations in autism spectrum disorders
Molecular Autism 2016cited by 470position: middledoi
Adjunctive minocycline for schizophrenia: A meta-analysis of randomized controlled trials
European Neuropsychopharmacology 2016cited by 84position: middledoi
Clozapine-induced agranulocytosis is associated with rare HLA-DQB1 and HLA-B alleles
Nature Communications 2014cited by 180position: middledoi
Reduced arterial compliance in patients with psychiatric diagnoses
Schizophrenia Research 2012cited by 9position: middledoi

Grants

Collaborative Research: SCH: Using Multi-Stage Learning to Prioritize Mental Health Risk Using Evidence from Speech and Text
NSF2124224$331,5652021–2026PIRePORTER

Frequent collaborators

John M. Kane · North Shore Diabetes and Endocrine Associates4 papers (2020–2025)Christoph U. Correll · Champlain Regional College3 papers (2020–2025)Oliver Howes · King's College London2 papers (2020–2025)Nick Myles · University of Queensland2 papers (2020–2025)Robert O. Cotes · Emory University2 papers (2025–2025)Oliver Freudenreich · Tufts University2 papers (2020–2020)James H. MacCabe · King's College London1 papers (2020–2020)Robert A. McCutcheon · Oxford Health NHS Foundation Trust1 papers (2025–2025) · 1 papers (2020–2020)Gerhard Gründer · Johannes Gutenberg University Mainz1 papers (2020–2020)Peter F.J. Schulte · Utrecht University1 papers (2020–2020)John W. Newcomer · Washington University in St. Louis1 papers (2020–2020)Gerald Zernig · Johannes Gutenberg University Mainz1 papers (2020–2020)Stephen R. Marder · West Los Angeles College1 papers (2020–2020)Nicole Korman · Indiana University School of Medicine1 papers (2025–2025)Amanda Wheeler · Palo Alto University1 papers (2020–2020)Pierre Baumann · Zero to Three1 papers (2020–2020)Chee H. Ng · The University of Western Australia1 papers (2016–2016) · 1 papers (2016–2016)Jimmy Lee · National University of Singapore1 papers (2020–2020)